{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:49:54Z","timestamp":1767340194129,"version":"build-2065373602"},"reference-count":46,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T00:00:00Z","timestamp":1658016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Orthotopic liver transplantation (OLT) is a lifesaving therapy for patients with irreversible liver damage caused by autoimmune liver diseases (AutoD) including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC). Currently, it is unclear how access to transplantation differs among patients with various etiologies of liver disease. Our aim is to evaluate the likelihood of transplant and the long-term patient and graft survival after OLT for each etiology for transplantation from 2000 to 2021. We conducted a large retrospective study of United Network for Organ Sharing (UNOS) liver transplant patients in five 4-year eras with five cohorts: AutoD (PBC, PSC, AIH cirrhosis), alcohol-related liver disease (ALD), hepatocellular carcinoma (HCC), viral hepatitis, and nonalcoholic steatohepatitis (NASH). We conducted a multivariate analysis for probability of transplant. Intent-to-treat (ITT) analysis was performed to assess the 10-year survival differences for each listing diagnosis while accounting for both waitlist and post-transplant survival. Across all eras, autoimmune conditions had a lower adjusted probability of transplant of 0.92 (0.92, 0.93) compared to ALD 0.97 (0.97, 0.97), HCC 1.08 (1.07, 1.08), viral hepatitis 0.99 (0.99, 0.99), and NASH 0.99 (0.99, 1.00). Patients with AutoD had significantly better post-transplant patient and graft survival than ALD, HCC, viral hepatitis, and NASH in each and across all eras (p-values all &lt; 0.001). Patients with AutoD had superior ITT survival (p-value &lt; 0.001, log rank test). In addition, the waitlist survival for patients with AutoD compared to other listing diagnoses was improved with the exception of ALD, which showed no significant difference (p-value = 0.1056, log rank test). Despite a superior 10-year graft and patient survival in patients transplanted for AutoD, patients with AutoD have a significantly lower probability of receiving a liver transplant compared to those transplanted for HCC, ALD, viral hepatitis, and NASH. Patients with AutoD may benefit from improved liver allocation while maintaining superior waitlist and post-transplant survival. Decreased access in spite of appropriate outcomes for patients poses a significant risk for increased morbidity for patients with AutoD.<\/jats:p>","DOI":"10.3390\/jpm12071159","type":"journal-article","created":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T22:57:06Z","timestamp":1658098626000},"page":"1159","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Do Patients with Autoimmune Conditions Have Less Access to Liver Transplantation despite Superior Outcomes?"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-8276","authenticated-orcid":false,"given":"Stephanie S.","family":"Keeling","sequence":"first","affiliation":[{"name":"Department of Student Affairs, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm F.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Medical Scientist Training Program, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6673-6251","authenticated-orcid":false,"given":"Adrish","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Student Affairs, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4123-8336","authenticated-orcid":false,"given":"Cameron R.","family":"Goff","sequence":"additional","affiliation":[{"name":"Department of Student Affairs, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline R.","family":"Christmann","sequence":"additional","affiliation":[{"name":"Department of Student Affairs, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer C.","family":"Barrett","sequence":"additional","affiliation":[{"name":"Department of Student Affairs, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2509-0877","authenticated-orcid":false,"given":"Michael","family":"Kueht","sequence":"additional","affiliation":[{"name":"Transplant Surgery, Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Goss","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplant, Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Cholankeril","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplant, Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Rana","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplant, Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/alcalc\/agx105","article-title":"Transplantation for alcohol-related liver disease: Is it fair?","volume":"53","author":"Mellinger","year":"2018","journal-title":"Alcohol Alcohol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent Primary Biliary Cirrhosis After Liver Transplantation","volume":"10","author":"Silveira","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin. Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: A single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl. Int."},{"key":"ref_6","unstructured":"Futagawa, Y., and Terasaki, P. (2004). An analysis of the OPTN\/UNOS Liver Transplant Registry. Clin. Transpl., 315\u2013329."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/00007890-200011150-00012","article-title":"Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus1","volume":"70","author":"Jain","year":"2000","journal-title":"Transplantation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jamcollsurg.2012.02.022","article-title":"Liver Transplantation for Hepatocellular Carcinoma: Long-Term Results Suggest Excellent Outcomes","volume":"215","author":"Doyle","year":"2012","journal-title":"J. Am. Coll. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/lt.22435","article-title":"Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States","volume":"18","author":"Afzali","year":"2011","journal-title":"Liver Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jcag\/gwaa022","article-title":"Single-Center North American Experience of Liver Transplantation in Autoimmune Hepatitis: Infrequent Indication but Good Outcomes for Patients","volume":"4","author":"Onofrio","year":"2020","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(03)00283-6","article-title":"Liver transplantation for primary biliary cirrhosis: Indications and risk of recurrence","volume":"39","author":"Neuberger","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic Liver Transplantation for Primary Scierosing Cholangitis A 12-Year Single Center Experience","volume":"225","author":"Goss","year":"1997","journal-title":"Ann. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000658-200010000-00004","article-title":"Long-Term Survival after Liver Transplantation in 4000 Consecutive Patients at a Single Center","volume":"232","author":"Jain","year":"2000","journal-title":"Ann. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/lt.20137","article-title":"Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database","volume":"10","author":"Roberts","year":"2004","journal-title":"Liver Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1001\/jama.2008.732","article-title":"Race and Sex Disparities in Liver Transplantation","volume":"300","author":"Axelrod","year":"2008","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1600-6143.2007.01666.x","article-title":"Female Liver Transplant Recipients with the Same GFR as Male Recipients Have Lower MELD Scores? A Systematic Bias","volume":"7","author":"Cholongitas","year":"2007","journal-title":"Am. J. Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/jlts.2001.24638","article-title":"Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient","volume":"7","author":"Hurtova","year":"2001","journal-title":"Liver Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/lt.23704","article-title":"Liver transplantation and autoimmune liver diseases","volume":"19","author":"Liberal","year":"2013","journal-title":"Liver Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.transproceed.2007.02.030","article-title":"Liver Transplantation for Autoimmune Hepatitis: A Single-Center Experience","volume":"39","author":"Khalaf","year":"2007","journal-title":"Transplant. Proc."},{"key":"ref_21","first-page":"434","article-title":"Liver Transplant in Patients with Primary Sclerosing Cholangitis: Long-Term Experience of a Single Center","volume":"16","author":"Astarcioglu","year":"2018","journal-title":"Exp. Clin. Transplant."},{"key":"ref_22","first-page":"S9","article-title":"Liver Transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: Does medical treatment alter timing and selection?","volume":"4","author":"Hay","year":"1998","journal-title":"Liver Transplant. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: A meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients with Primary Biliary Cirrhosis: An International Follow-up Study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","article-title":"Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis","volume":"110","author":"Lindor","year":"1996","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5582\/irdr.2014.01034","article-title":"Liver transplantation and autoimmune hepatitis","volume":"4","author":"Tanaka","year":"2015","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: A systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bpg.2018.09.001","article-title":"PBC-transplantation and disease recurrence","volume":"34","author":"Nevens","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/jlts.2003.50132","article-title":"The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation","volume":"9","author":"Levitsky","year":"2003","journal-title":"Liver Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2015","journal-title":"Liver Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early Liver Transplantation for Severe Alcoholic Hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.21037\/tgh.2019.11.17","article-title":"Liver transplantation for alcoholic hepatitis","volume":"5","author":"Shipley","year":"2020","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/hep.32067","article-title":"Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA","volume":"74","author":"Cholankeril","year":"2021","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamasurg.2021.3748","article-title":"Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease","volume":"156","author":"Punchhi","year":"2021","journal-title":"JAMA Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9198","DOI":"10.3748\/wjg.v19.i48.9198","article-title":"Long-term survival after liver transplantation for alcoholic liver disease","volume":"19","author":"Iruzubieta","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S524","DOI":"10.1097\/01.tp.0000701332.76343.ac","article-title":"Oncologic outcomes of alcohol induced HCC after liver transplantation","volume":"104","author":"Joo","year":"2020","journal-title":"Transplantation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2013.09.023","article-title":"Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis","volume":"12","author":"Wang","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0016-5085(92)91129-R","article-title":"Recurrent and acquired hepatitis C viral infection in liver transplant recipients","volume":"103","author":"Wright","year":"1992","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_41","first-page":"203","article-title":"Viral Hepatitis Long-Term Outcome of Hepatitis C Virus Infection after Liver Transplantation","volume":"25","author":"Dalley","year":"1997","journal-title":"Viral Hepat."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00000658-200109000-00012","article-title":"A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in over 500 Patients","volume":"234","author":"Ghobrial","year":"2001","journal-title":"Ann. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/hep.1840210107","article-title":"Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation","volume":"21","author":"Sheiner","year":"1995","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/00007890-199805150-00006","article-title":"Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury1","volume":"65","author":"Rosen","year":"1998","journal-title":"Transplantation"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/lt.500050602","article-title":"Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin","volume":"5","author":"Yoshida","year":"1999","journal-title":"Liver Transplant. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.3748\/wjg.v26.i18.2166","article-title":"Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger?","volume":"26","author":"Lenci","year":"2020","journal-title":"World J. Gastroenterol."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/7\/1159\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:52:30Z","timestamp":1760140350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/7\/1159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,17]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["jpm12071159"],"URL":"https:\/\/doi.org\/10.3390\/jpm12071159","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2022,7,17]]}}}